BioCentury
ARTICLE | Financial News

Angion files for IPO

April 15, 2014 11:30 PM UTC

Angion Biomedica Corp. (Uniondale, N.Y.) filed to raise up to $34.5 million in an IPO on NASDAQ underwritten by Aegis Capital. Angion's BB3 is in Phase II testing to treat delayed graft function in re...